PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-05-20

Date Title Company
20-May-2026 ImmunityBio Announces FDA Acceptance of Supplemental BLA for ANKTIVA® Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Papillary Disease; PDUFA Date Set for January 6, 2027 Businesswire